Literature DB >> 10524629

Long-term in vivo reconstitution of T-cell development by Pax5-deficient B-cell progenitors.

A G Rolink1, S L Nutt, F Melchers, M Busslinger.   

Abstract

The mechanisms controlling the commitment of haematopoietic progenitors to the B-lymphoid lineage are poorly understood. The observations that mice deficient in E2A and EBF lack B-lineage cells have implicated these two transcription factors in the commitment process. Moreover, the expression of genes encoding components of the rearrangement machinery (RAG1, RAG2, TdT) or pre-B-cell receptor (lambda5, VpreB, Igalpha, Igbeta) has been considered to indicate B-lineage commitment. All these genes including E2A and EBF are expressed in pro-B cells lacking the transcription factor Pax5. Here we show that cloned Pax5-deficient pro-B cells transferred into RAG2-deficient mice provide long-term reconstitution of the thymus and give rise to mature T cells expressing alpha/beta-T-cell receptors. The bone marrow of these mice contains a population of cells of Pax5-/- origin with the same phenotype as the donor pro-B cells. When transferred into secondary recipients, these pro-B cells again home to the bone marrow and reconstitute the thymus. Hence, B-lineage commitment is determined neither by immunoglobulin DJ rearrangement nor by the expression of E2A, EBF, lambda5, VpreB, Igalpha and Igbeta. Instead, our data implicate Pax5 in the control of B-lineage commitment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10524629     DOI: 10.1038/44164

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  77 in total

Review 1.  Review article: role of the surrogate light chain and the pre-B-cell receptor in mouse B-cell development.

Authors:  I L Mårtensson; R Ceredig
Journal:  Immunology       Date:  2000-12       Impact factor: 7.397

2.  Transcriptional repression by Pax5 (BSAP) through interaction with corepressors of the Groucho family.

Authors:  D Eberhard; G Jiménez; B Heavey; M Busslinger
Journal:  EMBO J       Date:  2000-05-15       Impact factor: 11.598

3.  Differential endocytotic characteristics of a novel human B/DC cell line HBM-Noda: effective macropinocytic and phagocytic function rather than scavenging function.

Authors:  I Torii; S Morikawa; M Nagasaki; A Nokano; K Morikawa
Journal:  Immunology       Date:  2001-05       Impact factor: 7.397

4.  Nuclear reprogramming in cell-free extracts.

Authors:  Philippe Collas
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-08-29       Impact factor: 6.237

5.  Transcription factor-mediated lineage switching reveals plasticity in primary committed progenitor cells.

Authors:  Clare Heyworth; Stella Pearson; Gillian May; Tariq Enver
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

6.  Myeloid lineage switch of Pax5 mutant but not wild-type B cell progenitors by C/EBPalpha and GATA factors.

Authors:  Barry Heavey; Christoforos Charalambous; Cesar Cobaleda; Meinrad Busslinger
Journal:  EMBO J       Date:  2003-08-01       Impact factor: 11.598

7.  A new Groucho TLE4 protein may regulate the repressive activity of Pax5 in human B lymphocytes.

Authors:  Michèle Milili; Laurent Gauthier; Julie Veran; Marie-Geneviève Mattei; Claudine Schiff
Journal:  Immunology       Date:  2002-08       Impact factor: 7.397

8.  B cell-specific loss of histone 3 lysine 9 methylation in the V(H) locus depends on Pax5.

Authors:  Kristen Johnson; David L Pflugh; Duonan Yu; David G T Hesslein; Kuo-I Lin; Alfred L M Bothwell; Andrei Thomas-Tikhonenko; David G Schatz; Kathryn Calame
Journal:  Nat Immunol       Date:  2004-07-18       Impact factor: 25.606

9.  Highly conserved amino acids in Pax and Ets proteins are required for DNA binding and ternary complex assembly.

Authors:  D Fitzsimmons; R Lutz; W Wheat; H M Chamberlin; J Hagman
Journal:  Nucleic Acids Res       Date:  2001-10-15       Impact factor: 16.971

Review 10.  Transcriptional regulation of early B cell development.

Authors:  Daniel L Northrup; David Allman
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.